Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
(NASDAQ:DNTH), NEW YORK and WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the Company's participation in the Jefferies Global Healthcare Conference. Marino Garcia, Chief Executive Officer, will participate in […]